As genomics continues to evolve, here are five things to know about genetic testing and counseling.
When it comes to cancer, the idea that genetic information can be used to shape personalized care has captivated the public’s imagination. As a result, payers face intense pressure from employers, laboratories and members to cover every promising new genomic test on the market.
Yet, just because a test exists doesn’t mean we fully understand the best ways to apply it. In the rapidly expanding science of genomics, technology often outpaces the ability to use it to improve patient outcomes, or even to accurately interpret the results. This means managed care executives today have tremendous opportunities to help promote the most current, evidence-based use of genetic tests in oncology care.
As genomics continues to evolve, here are five things to know about genetic testing and counseling to ensure that payers, patients and providers are getting the most out of these exciting technologies and the care they can inform:
Precision medicine fueled by genetic testing is an exciting goal that nearly everyone embraces. But it is critical to separate the hype from evidence-based strategies in order to improve outcomes and minimize harm. When backed by deep genomics expertise, managed care executives can help support this goal by enforcing more evidence-based policies and promoting greater education and more research around these tests.
Rebecca Sutphen, MD, FACMG, is president and chief medical officer at InformedDNA, the nation's largest independent provider of genetics expert services.